Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers
This Review discuss approaches to the management of central nervous system (CNS) metastases for non–small cell lung cancer with the incorporation of molecular and genomic markers in the treatment paradigms.